Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Fire at Anakapalli pharma plant, no injuries reported

Ruchika Sharma21 Jan 2025 12:51 PM IST

Anakapalli: Fire erupted at a Anakapalli pharmaceutical company on Tuesday morning. The flames were extenguished within 20 minutes, according to a...

Ciplas Lanreotide Supply in US Hit After USFDA Observations at Pharmathen Facility

Cipla Goa facility gets one USFDA observation

Ruchika Sharma21 Jan 2025 11:30 AM IST

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the manufacturing...

Shalby receives USFDA clearance for knee replacement device

Ruchika Sharma21 Jan 2025 10:00 AM IST

Shalby Advanced Technologies Inc., USA, a step down subsidiary of the Company has received U.S. Food and Drug Administration (FDA) 510(k) Premarket ...

Strides Pharma Science Acetaminophen and Ibuprofen Tablets

Strides Pharma Science arm gets USFDA nod for Acetaminophen and Ibuprofen Tablets

Ruchika Sharma20 Jan 2025 4:52 PM IST

Bangalore: Strides Pharma Science Limited has announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

AstraZeneca-Daiichi Sankyo Datroway gets USFDA nod for previously treated Metastatic HR Positive, HER2 Negative Breast Cancer

Ruchika Sharma20 Jan 2025 3:01 PM IST

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult...

Exempt cancer, rare-disease drugs from tax in budget: Biocon Chief urges govt

Ruchika Sharma20 Jan 2025 1:06 PM IST

Kiran Mazumdar-Shaw, Chairperson of Biocon, has urged the government to remove tax on medicines used to treat cancer, chronic illnesses, and rare...

GMC eluru 6 mbbs students bitten by rats in hostel room, Health Minister orders inquiry

JnK: Govt supplied medicines found dumped in Rajouri, investigation ordered

Ruchika Sharma20 Jan 2025 11:30 AM IST

Rajouri: A large quantity of government-supplied medicines was discovered abandoned in a gorge near Budhkhanari in Darhal tehsil of Rajouri district,...

Zydus Lifesciences gets USFDA nod to conduct Phase II(b) clinical trial for Usnoflast for Amyotrophic Lateral Sclerosis

Ruchika Sharma19 Jan 2025 2:45 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that it has received approval from USFDA to conduct Phase...

Online weight loss drug dangers flagged by Outgoing USFDA chief

Ruchika Sharma19 Jan 2025 11:15 AM IST

Wahington: Outgoing U.S. Food and Drug Administration (USFDA) Commissioner Robert Califf stated on Thursday that existing laws and regulations...

Cipla hit with over Rs 9 crore GST penalty, plans appeal

Ruchika Sharma18 Jan 2025 3:20 PM IST

Drug major Cipla has been hit with a penalty of Rs 9.77 crore by the GST Authority for alleged tax violations under the Central Goods and Services Tax...

AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer

USFDA approves AstraZeneca Calquence, bendamustine, rituximab combo for previously untreated mantle cell lymphoma

Ruchika Sharma18 Jan 2025 1:30 PM IST

Cambridge: AstraZeneca has announced that the Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) in combination with...

Bajaj Healthcare appoints Shreekumar Shankarnarayan Nair as Chief Operating Officer

Bajaj Healthcare gets rights to manufacture, distribute, sell Magnesium L Threonate in India

Ruchika Sharma18 Jan 2025 12:30 PM IST

Mumbai: Bajaj Healthcare Limited has announced that it has received exclusive rights for manufacturing, distribution and sales of the finished...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok